Chronic myeloid leukaemia News and Research

RSS
Combination of MEK inhibitors and nilotinib can overcome CML resistance to targeted drug

Combination of MEK inhibitors and nilotinib can overcome CML resistance to targeted drug

Glasgow Professor discusses about new approach for CML treatment at UK conference

Glasgow Professor discusses about new approach for CML treatment at UK conference

Scientists to commence new DNA vaccine trial for use in patients with leukemia

Scientists to commence new DNA vaccine trial for use in patients with leukemia

Cancer Research UK launches new Centre in Glasgow

Cancer Research UK launches new Centre in Glasgow

New OncoMap technique can detect point mutation in ovarian cancer

New OncoMap technique can detect point mutation in ovarian cancer

Scientists develop new mathematical model to understand CML better

Scientists develop new mathematical model to understand CML better

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

Scientists identify new potential drug for treating acute myeloid leukaemia

Scientists identify new potential drug for treating acute myeloid leukaemia

Glivec the best news yet for cancer victims

Glivec the best news yet for cancer victims

New era drug gives hope to Gleevec resistant leukaemia sufferers

New era drug gives hope to Gleevec resistant leukaemia sufferers

Vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia

Vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.